First Drug to Reduce Proteinuria in Berger's Disease.

Diane S Aschenbrenner

The American journal of nursing 2022 Apr 01

filter terms:

Budesonide (Tarpeyo) has received accelerated approval to reduce proteinuria in adults with primary immunoglobulin A nephropathy, also known as Berger's disease.Nurses should assess if any coprescribed drugs could induce a drug-drug interaction via the cytochrome P-450 isoenzyme system. Because budesonide causes immunosuppression, patients are at high risk for developing infections and should be told to avoid anyone who is known to have an infection. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.